# A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

> **NCT07141706** · PHASE1 · RECRUITING · sponsor: **DualityBio Inc.** · enrollment: 233 (estimated)

## Conditions studied

- Advanced/Metastatic Solid Tumors

## Interventions

- **DRUG:** DB-1317

## Key facts

- **NCT ID:** NCT07141706
- **Lead sponsor:** DualityBio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-23
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 233 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07141706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07141706, "A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07141706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*